Loading
Latest filing published 19 Mar 2026 for 경보제약, €6,454.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
홍성상 (chief executive) discloses dealings in 경보제약 to DART (FSS). Between 27 February 2026 and 17 March 2026, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 2 purchases, €6,454 in total. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 19 March 2026 came the latest disclosure, an open-market purchase for €6,454 in 경보제약. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.